LPCN long set up

5 Şub 2021

No investment advice!

I do this only for practicing.

I see a cup and handle

Very nice risk / reward here.

Upcoming Catalysts:

LPCN 1144
Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH)

Phase 2

Mid-2021
Phase 2 top-line change in liver fat data met primary endpoint January 12, 2021. 36-week biopsy data are expected mid-2021.

24 Şub 2021

İşlem kapandı: durdurma seviyesi

SL hit